Introduction to Clinical Trials and Drug Development
Definition and Overview Clinical trials and drug development constitute a systematic, evidence‑based process by which new therapeutic agents are investigated, evaluated, and…
Topic Archive
Category: Uncategorized
Cholinergic Neurotransmission
Introduction Definition and Overview Cholinergic neurotransmission constitutes the signaling pathway mediated by acetylcholine (ACh) as the principal neurotransmitter. This system orchestrates a…
Anticholinesterase Agents (Reversible and Irreversible)
1. Introduction / Overview Anticholinesterase agents constitute a pharmacological class that modulates cholinergic neurotransmission by inhibiting the enzymatic hydrolysis of acetylcholine (ACh).…
Management of Organophosphorus Poisoning
Introduction Definition and Overview Organophosphorus (OP) compounds constitute a class of chemicals widely employed as pesticides, nerve agents, and industrial intermediates. Their…
Chapter 10: Anticholinergic Drugs (Muscarinic Antagonists)
Introduction/Overview Overview Muscarinic antagonists, commonly referred to as anticholinergic drugs, constitute a diverse group of agents that inhibit the action of acetylcholine…
Adrenergic Neurotransmission
Introduction Adrenergic neurotransmission refers to the process by which adrenergic (noradrenergic and adrenergic) neurons communicate with target cells through the release of…
Adrenergic Agonists (Catecholamines and Non-Catecholamines)
Introduction / Overview Adrenergic agonists encompass a diverse array of pharmacologic agents that stimulate adrenergic receptors, thereby modulating cardiovascular, respiratory, and metabolic…
Alpha‑Adrenergic Blockers: Pharmacology and Clinical Applications
Introduction / Overview Alpha‑adrenergic blockers comprise a diverse group of agents that selectively inhibit alpha‑adrenergic receptors, thereby modulating sympathetic nervous system activity.…
Beta‑Adrenergic Blockers
Introduction/Overview Beta‑adrenergic blockers (β‑blockers) constitute a pivotal class of cardiovascular therapeutics that have expanded into diverse clinical arenas. Their capacity to inhibit…
Drugs for Glaucoma
Introduction / Overview Glaucoma represents a group of optic neuropathies that are principal causes of irreversible visual loss worldwide. The disease spectrum…